MR
Mahesh Rameshbhai Sarvaiya
About Mahesh Rameshbhai Sarvaiya
Data last updated:
Mahesh Rameshbhai Sarvaiya is a Director at Bristal Life Science Private Limited (since 2017), Director at Unesto Pharma Private Limited (since 2019) and Director at Evoria Bioscience Private Limited (since 2023). The companies operate in Business Services, Chemicals and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹27.9 Lakh; the largest is Bristal Life Science Private Limited at ₹25.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bristal Life Science Private Limited U74999GJ2017PTC096737 | Director | 07 Apr 2017 | 2017 | ₹25.7 Lakh (FY 2025) | Active |
| Unesto Pharma Private Limited U24110GJ2019PTC109176 | Director | 18 Jul 2019 | 2019 | ₹2.2 Lakh (FY 2025) | Active |
| Evoria Bioscience Private Limited U21001GJ2023PTC146477 | Director | 24 Nov 2023 | 2023 | Active |
Board colleagues of Mahesh Rameshbhai Sarvaiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Niru Maheshbhai Sarvaiya | 08837669 | Bristal Life Science Private Limited | Director |
| Jaydip Girishchandra Dave | 09525404 | Unesto Pharma Private Limited | Director |
| Bhajanananda Ray | 10404261 | Evoria Bioscience Private Limited | Director |
| Jay Chetankumar Bhatt | 10404260 | Evoria Bioscience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Rameshbhai Sarvaiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Rameshbhai Sarvaiya
Mahesh Rameshbhai Sarvaiya currently holds 3 directorships: Bristal Life Science Private Limited (Director, since 07 Apr 2017, revenue ₹25.7 Lakh (FY 2025)); Unesto Pharma Private Limited (Director, since 18 Jul 2019, revenue ₹2.2 Lakh (FY 2025)); Evoria Bioscience Private Limited (Director, since 24 Nov 2023).
Mahesh Rameshbhai Sarvaiya was first appointed on 07 Apr 2017 as Director at Bristal Life Science Private Limited. The most recent appointment on record is 24 Nov 2023 at Evoria Bioscience Private Limited.
The 2 current companies of Mahesh Rameshbhai Sarvaiya that report revenue have a combined latest revenue of ₹27.9 Lakh: Bristal Life Science Private Limited ₹25.7 Lakh (FY 2025); Unesto Pharma Private Limited ₹2.2 Lakh (FY 2025).
The current boards of Mahesh Rameshbhai Sarvaiya's companies include Niru Maheshbhai Sarvaiya (Bristal Life Science Private Limited), Jaydip Girishchandra Dave (Unesto Pharma Private Limited), Bhajanananda Ray (Evoria Bioscience Private Limited), Jay Chetankumar Bhatt (Evoria Bioscience Private Limited).